These Regulations provide, in regulations 6 and 7, for the cannabis-based medicine “Sativex” to be placed in Part 1 of Schedule 4 to the Misuse of Drugs Regulations 2001. Regulation 4 inserts new paragraph (5) into regulation 22 which provides that a person, other than those persons specified in new paragraph (6), who is authorised to possess or to destroy, or cause to be destroyed, “Sativex” shall make a record of the quantity possessed or destroyed, and regulation 5 excepts a person who makes such a record under new regulation 22(5) from the requirements relating to the destruction of controlled drugs contained in regulation 27(1) or (3) of the Misuse of Drugs Regulations 2001.

A full impact assessment of the effect that this instrument will have on the costs of business and the voluntary sector is available and is published with the Explanatory Memorandum alongside the instrument on www.legislation.gov.uk.